Despite the research on the antitumour and antimetastatic activities of PEDF, little is known about its exact molecular mechanism of tumour growth and progression in response to glycaemic loading, and subsequently the metabolic responses when tumour cells are exposed to PEDF. Here, SERPINF1 is linked to neoplasm.